Emmessar Biotech & Nutrition informs about board meeting outcome

09 Dec 2023 Evaluate

Emmessar Biotech & Nutrition has informed that the Board of Directors at their meeting approved and took on record the Un-Audited Financial Results for the second quarter ended September 30, 2023.

The above information is a part of company’s filings submitted to BSE.


Emmessar Biotech&Nut Share Price

43.05 0.76 (1.80%)
29-Apr-2024 11:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1521.85
Dr. Reddys Lab 6277.25
Cipla 1395.95
Zydus Lifesciences 960.20
Lupin 1637.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.